MAIL regulates human monocyte IL-6 production

Journal of Immunology

Volumn 183, Issue 8, 2009, Pages 5358-5368

  Seshadri, Sudarshan ^a   Kannan, Yashaswini ^a   Mitra, Srabani ^a   Parker Barnes, Jennifer ^a   Wewers, Mark D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; CCAAT ENHANCER BINDING PROTEIN BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LUCIFERASE; MOLECULE CONTAINING ANKYRIN REPEATS INDUCED BY LIPOPOLYSACCHARIDE; MURAMYL DIPEPTIDE; PROTEIN SUBUNIT; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; INFLAMMATION; KNOCKOUT MOUSE; MOLECULAR WEIGHT; MONOCYTE; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; CELL LINE; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES; NF-KAPPA B P50 SUBUNIT; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954116849     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802736     Document Type: Article

References (63)

1. Kitamura, H., K. Kanehira, K. Okita, M. Morimatsu, and M. Saito. 2000. MAIL, a novel nuclear I κ B protein that potentiates LPS-induced IL-6 production. FEBS Lett. 485: 53-56.
2. Yamazaki, S., T. Muta, and K. Takeshige. 2001. A novel IκB protein, IκB-ζ, induced by proinflammatory stimuli, negatively regulates nuclear factor-κB in the nuclei. J. Biol. Chem. 276: 27657-27662.
3. Haruta, H., A. Kato, and K. Todokoro. 2001. Isolation of a novel interleukin-1- inducible nuclear protein bearing ankyrin-repeat motifs. J. Biol. Chem. 276: 12485-12488.
4. Eto, A., T. Muta, S. Yamazaki, and K. Takeshige. 2003. Essential roles for NF-κ B and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I κ B-ζ. Biochem. Biophys. Res. Commun. 301: 495-501.
5. Ito, T., M. Morimatsu, T. Oonuma, T. Shiina, H. Kitamura, and B. Syuto. 2004. Transcriptional regulation of the MAIL gene in LPS-stimulated RAW264 mouse macrophages. Gene 342: 137-143.
6. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-κB signaling. Cell 132: 344-362.
7. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-κB. Genes Dev. 18: 2195-2224.
8. Hirotani, T., P. Y. Lee, H. Kuwata, M. Yamamoto, M. Matsumoto, I. Kawase, S. Akira, and K. Takeda. 2005. The nuclear IκB protein IκBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J. Immunol. 174: 3650-3657. (Pubitemid 40354075)
9. Kuwata, H., M. Matsumoto, K. Atarashi, H. Morishita, T. Hirotani, R. Koga, and K. Takeda. 2006. IκBNS inhibits induction of a subset of Toll-like receptordependent genes and limits inflammation. Immunity 24: 41-51.
10. Motoyama, M., S. Yamazaki, A. Eto-Kimura, K. Takeshige, and T. Muta. 2005. Positive and negative regulation of nuclear factor-κB-mediated transcription by IκB-ζ, an inducible nuclear protein. J. Biol. Chem. 280: 7444-7451.
11. Totzke, G., F. Essmann, S. Pohlmann, C. Lindenblatt, R. U. Janicke, and K. Schulze-Osthoff. 2006. A novel member of the IκB family, human IκB-ζ, inhibits transactivation of p65 and its DNA binding. J. Biol. Chem. 281: 12645-12654.
12. Yamamoto, M., S. Yamazaki, S. Uematsu, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Kuwata, O. Takeuchi, K. Takeshige, T. Saitoh, S. Yamaoka, N. Yamamoto, S. Yamamoto, T. Muta, K. Takeda, and S. Akira. 2004. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ. Nature 430: 218-222.
13. Kao, C. Y., C. Kim, F. Huang, and R. Wu. 2008. Requirements for two proximal NF-κB binding sites and IκB-ζ in IL-17A-induced human β-defensin 2 expression by conducting airway Epithelium. J. Biol. Chem. 283: 15309-15318.
14. Cowland, J. B., T. Muta, and N. Borregaard. 2006. IL-1β-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IκB-ζ. J. Immunol. 176: 5559-5566.
15. Trinh, D. V., N. Zhu, G. Farhang, B. J. Kim, and T. Huxford. 2008. The nuclear I κB protein IκBζ specifically binds NF-κB p50 homodimers and forms a ternary complex on κB DNA. J. Mol. Biol. 379: 122-135.
16. Elssner, A., M. Duncan, M. Gavrilin, and M. D. Wewers. 2004. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release. J. Immunol. 172: 4987-4994. (Pubitemid 38456425)
17. Gavrilin, M. A., I. J. Bouakl, N. L. Knatz, M. D. Duncan, M. W. Hall, J. S. Gunn, and M. D. Wewers. 2006. Internalization and phagosome escape required for Francisella to induce human monocyte IL-1β processing and release. Proc. Natl. Acad. Sci.USA 103: 141-146.
18. Eickelberg, O., M. Roth, R. Mussmann, J. J. Rudiger, M. Tamm, A. P. Perruchoud, and L. H. Block. 1999. Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-κB in primary human vascular smooth muscle cells. Circulation 99: 2276-2282.
19. Eickelberg, O., A. Pansky, R. Mussmann, M. Bihl, M. Tamm, P. Hildebrand, A. P. Perruchoud, and M. Roth. 1999. Transforming growth factor-β1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J. Biol. Chem. 274: 12933-12938.
20. Cahill, C. M., and J. T. Rogers. 2008. Interleukin (IL) 1β induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IκB kinase α pathway targeting activator protein-1. J. Biol. Chem. 283: 25900-25912.
21. Herzyk, D. J., J. N. Allen, C. B. Marsh, and M. D. Wewers. 1992. Macrophage and monocyte IL-1 β regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing. J. Immunol. 149: 3052-3058.
22. Marsh, C. B., M. P. Lowe, B. H. Rovin, J. M. Parker, Z. Liao, D. L. Knoell, and M. D. Wewers. 1998. Lymphocytes produce IL-1β in response to Fcγ receptor cross-linking: effects on parenchymal cell IL-8 release. J. Immunol. 160: 3942-3948.
23. Marsh, C. B., J. E. Gadek, G. C. Kindt, S. A. Moore, and M. D. Wewers. 1995. Monocyte Fc γ receptor cross-linking induces IL-8 production. J. Immunol. 155: 3161-3167.
24. Muta, T., S. Yamazaki, A. Eto, M. Motoyama, and K. Takeshige. 2003. IκB-ζ, a new anti-inflammatory nuclear protein induced by lipopolysaccharide, is a negative regulator for nuclear factor-κB. J. Endotoxin Res. 9: 187-191.
25. Wewers, M. D., H. A. Dare, A. V. Winnard, J. M. Parker, and D. K. Miller. 1997. IL-1 β-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1β release limitation is ICE independent. J. Immunol. 159: 5964-5972.
26. Wewers, M. D., and D. J. Herzyk. 1989. Alveolar macrophages differ from blood monocytes in human IL-1β release. Quantitation by enzyme-linked immunoassay. J. Immunol. 143: 1635-1641.
27. Wewers, M. D., S. I. Rennard, A. J. Hance, P. B. Bitterman, and R. G. Crystal. 1984. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J. Clin. Invest. 74: 2208-2218.
28. Yamazaki, S., T. Muta, S. Matsuo, and K. Takeshige. 2005. Stimulus-specific induction of a novel nuclear factor-κB regulator, IκB-ζ, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization. J. Biol. Chem. 280: 1678-1687.
29. Eto, A., T. Muta, S. Yamazaki, and K. Takeshige. 2003. Essential roles for NF-κ B and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I κ B-ζ. Biochem. Biophys. Res. Commun. 301: 495-501.
30. Dower, S. K., S. R. Kronheim, C. J. March, P. J. Conlon, T. P. Hopp, S. Gillis, and D. L. Urdal. 1985. Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J. Exp. Med. 162: 501-515.
31. Matsuo, S., S. Yamazaki, K. Takeshige, and T. Muta. 2007. Crucial roles of binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activation. Biochem.J. 405: 605-615. (Pubitemid 47172059)
32. Masumoto, J., K. Yang, S. Varambally, M. Hasegawa, S. A. Tomlins, S. Qiu, Y. Fujimoto, A. Kawasaki, S. J. Foster, Y. Horie, et al. 2006. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J. Exp. Med. 203: 203-213.
33. Strober, W., P. J. Murray, A. Kitani, and T. Watanabe. 2006. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 6: 9-20.
34. Werts, C., L. le Bourhis, J. Liu, J. G. Magalhaes, L. A. Carneiro, J. H. Fritz, S. Stockinger, V. Balloy, M. Chignard, T. Decker, et al. 2007. Nod1 and Nod2 induce CCL5/RANTES through the NF-κB pathway. Eur. J. Immunol. 37: 2499-2508.
35. da Silva, C. J., Y. Miranda, N. Leonard, J. Hsu, and R. J. Ulevitch. 2007. Regulation of Nod1-mediated signaling pathways. Cell Death. Differ. 14: 830-839.
36. Kim, Y. G., J. H. Park, M. H. Shaw, L. Franchi, N. Inohara, and G. Nunez. 2008. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity. 28: 246-257.
37. van Heel, D. A., S. Ghosh, K. A. Hunt, C. G. Mathew, A. Forbes, D. P. Jewell, and R. J. Playford. 2005. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 54: 1553-1557.
38. van Heel, D. A., S. Ghosh, M. Butler, K. Hunt, B. M. Foxwell, D. Mengin-Lecreulx, and R. J. Playford. 2005. Synergistic enhancement of Tolllike receptor responses by NOD1 activation. Eur.J. Immunol. 35: 2471-2476.
39. van Heel, D. A., S. Ghosh, M. Butler, K. A. Hunt, A. M. Lundberg, T. Ahmad, D. P. McGovern, C. Onnie, K. Negoro, S. Goldthorpe, et al. 2005. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 365: 1794-1796.
40. Takada, H., S. Yokoyama, and S. Yang. 2002. Enhancement of endotoxin activity by muramyldipeptide. J. Endotoxin. Res. 8: 337-342.
41. Uehara, A., S. Yang, Y. Fujimoto, K. Fukase, S. Kusumoto, K. Shibata, S. Sugawara, and H. Takada. 2005. Muramyldipeptide and diaminopimelic acidcontaining desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a. Cell Microbiol. 7: 53-61.
42. Yang, S., R. Tamai, S. Akashi, O. Takeuchi, S. Akira, S. Sugawara, and H. Takada. 2001. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 69: 2045-2053.
43. Pan, Q., J. Mathison, C. Fearns, V. V. Kravchenko, C. J. da Silva, H. M. Hoffman, K. S. Kobayashi, J. Bertin, E. P. Grant, A. J. Coyle, F. S. Sutterwala, Y. Ogura, R. A. Flavell, and R. J. Ulevitch. 2007. MDP-induced interleukin-1β processing requires Nod2 and CIAS1/NALP3. J. Leukocyte Biol. 82: 177-183.
44. Kitamura, H., Y. Matsushita, T. Iwanaga, K. Mori, K. Kanehira, D. Fujikura, M. Morimatsu, and M. Saito. 2003. Bacterial lipopolysaccharide-induced expression of the IκB protein MAIL in B-lymphocytes and macrophages. Arch. Histol. Cytol. 66: 53-62.
45. Scheller, J., N. Ohnesorge, and S. Rose-John. 2006. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand.J. Immunol. 63: 321-329.
46. Fink, M. P. 2006. The prevention and treatment of sepsis: is interleukin-6 a drug target or a drug? Crit. Care Med. 34: 919-921.
47. Rakoff-Nahoum, S., and R. Medzhitov. 2007. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124-127.
48. Naugler, W. E., T. Sakurai, S. Kim, S. Maeda, K. Kim, A. M. Elsharkawy, and M. Karin. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124.
49. Kotloff, R. M., J. Little, and J. A. Elias. 1990. Human alveolar macrophage and blood monocyte interleukin-6 production. Am.J. Respir. Cell Mol. Biol. 3: 497-505.
50. Bauer, J., U. Ganter, T. Geiger, U. Jacobshagen, T. Hirano, T. Matsuda, T. Kishimoto, T. Andus, G. Acs, and W. Gerok. 1988. Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood 72: 1134-1140.
51. Schneemann, M., and G. Schoedon. 2002. Species differences in macrophage NO production are important. Nat. Immunol. 3: 102.
52. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167: 1358-1363.
53. Schneemann, M., and G. Schoeden. 2007. Macrophage biology and immunology: man is not a mouse. J. Leukocyte Biol. 81: 579.
54. Albina, J. E. 1995. On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukocyte Biol. 58: 643-649. (Pubitemid 26032383)
55. Denis, M. 1994. Human monocytes/macrophages: NO or no NO? J. Leukocyte Biol. 55: 682-684. (Pubitemid 24171737)
56. Takashiba, S., T. E. Van Dyke, S. Amar, Y. Murayama, A. W. Soskolne, and L. Shapira. 1999. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor κB. Infect. Immun. 67: 5573-5578.
57. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell. 10: 417-426.
58. Fernandes-Alnemri, T., J. Wu, J. W. Yu, P. Datta, B. Miller, W. Jankowski, S. Rosenberg, J. Zhang, and E. S. Alnemri. 2007. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death. Differ. 14: 1590-1604.
59. Wang, Y., J. J. Zhang, W. Dai, and J. W. Pike. 1996. Production of granulocyte colony-stimulating factor by THP-1 cells in response to retinoic acid and phorbol ester is mediated through the autocrine production of interleukin-1. Biochem. Biophys. Res. Commun. 225: 639-646.
60. Muta, T. 2006. IκB-ζ: an inducible regulator of nuclear factor-κB. Vitam. Horm. 74: 301-316.
61. Kayama, H., V. R. Ramirez-Carrozzi, M. Yamamoto, T. Mizutani, H. Kuwata, H. Iba, M. Matsumoto, K. Honda, S. T. Smale, and K. Takeda. 2008. Classspecific regulation of pro-inflammatory genes by MyD88 pathways and IκBζ. J. Biol. Chem. 283: 12468-12477.
62. Shiina, T., A. Konno, T. Oonuma, H. Kitamura, K. Imaoka, N. Takeda, K. Todokoro, and M. Morimatsu. 2004. Targeted disruption of MAIL, a nuclear IκB protein, leads to severe atopic dermatitis-like disease. J. Biol. Chem. 279: 55493-55498.
63. Ueta, M., J. Hamuro, M. Yamamoto, K. Kaseda, S. Akira, and S. Kinoshita. 2005. Spontaneous ocular surface inflammation and goblet cell disappearance in I κ B ζ gene-disrupted mice. Invest. Ophthalmol. Vis. Sci. 46: 579-588.